Robert J. Kurman

Q: What Schools Are Affiliated With Robert J. Kurman

Robert J. Kurman is affiliated with the following schools: University of Oslo, Johns Hopkins University, National Taiwan University

Robert J. Kurman's AcademicInfluence.com Rankings

Robert J. Kurman

Biology

#3521

World Rank

#5377

Historical Rank

Pathology

#31

World Rank

#74

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Robert J. Kurman Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robert J. Kurman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The 2001 Bethesda System: terminology for reporting results of cervical cytology. (2002) (3229)
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective (1995) (3227)
Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions (2007) (1755)
WHO classification of tumours of female reproductive organs (2014) (1743)
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. (2005) (1693)
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory (2010) (1629)
BLAUSTEIN'S PATHOLOGY OF THE FEMALE GENITAL TRACT (1995) (1577)
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. (1995) (1300)
Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. (2004) (1240)
Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. (1993) (1237)
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm. (2011) (1001)
Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study (1991) (931)
Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. (2003) (842)
The behavior of endometrial hyperplasia. A long‐term study of “untreated” hyperplasia in 170 patients (1985) (819)
Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". (1995) (768)
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. (2009) (734)
The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded. (2016) (675)
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. (1999) (598)
Interim Guidelines for Management of Abnormal Cervical Cytology (1994) (556)
Ovarian Low-grade and High-grade Serous Carcinoma: Pathogenesis, Clinicopathologic and Molecular Biologic Features, and Diagnostic Problems (2009) (548)
The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses (1992) (537)
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. (2010) (533)
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years. (2009) (509)
Pathogenesis of Ovarian Cancer: Lessons From Morphology and Molecular Biology and Their Clinical Implications (2008) (509)
The Histologic Type and Stage Distribution of Ovarian Carcinomas of Surface Epithelial Origin (2004) (503)
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. (2006) (486)
The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. (1985) (479)
p16INK4a Immunohistochemistry Improves Interobserver Agreement in the Diagnosis of Cervical Intraepithelial Neoplasia (2002) (455)
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. (2009) (451)
High grade serous ovarian carcinomas originate in the fallopian tube (2017) (435)
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis: A Mutational Analysis With Immunohistochemical Correlation (2005) (428)
Histological Typing of Female Genital Tract Tumours (1994) (420)
Progestin Treatment of Atypical Hyperplasia and Well‐Differentiated Carcinoma of the Endometrium in Women Under Age 40 (1997) (417)
Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. (2011) (416)
Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. (1995) (414)
Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis (2011) (414)
Primary and Metastatic Mucinous Adenocarcinomas in the Ovaries: Incidence in Routine Practice With a New Approach to Improve Intraoperative Diagnosis (2003) (400)
Endodermal sinus tumor of the ovary. A clinical and pathologic analysis of 71 cases (1976) (397)
Systematic review of human papillomavirus prevalence in invasive penile cancer (2009) (390)
Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. (2000) (385)
p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. (1997) (383)
Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. (1994) (378)
Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis (2001) (365)
TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high‐grade serous carcinoma—evidence supporting the clonal relationship of the two lesions (2012) (347)
Diverse tumorigenic pathways in ovarian serous carcinoma. (2002) (345)
Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. (1998) (342)
p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. (1995) (341)
Uterine Serous Carcinoma A Morphologically Diverse Neoplasm With Unifying Clinicopathologic Features (1992) (326)
Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. (1996) (317)
The Bethesda System for reporting cervical/vaginal cytologic diagnoses: revised after the second National Cancer Institute Workshop, April 29-30, 1991. (1993) (313)
Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. (1996) (312)
Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. (1995) (307)
Oncogenic association of specific human papillomavirus types with cervical neoplasia. (1987) (305)
A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. (2001) (301)
PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. (1998) (298)
Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass. (2010) (289)
Origin and molecular pathogenesis of ovarian high-grade serous carcinoma. (2013) (281)
Notch3 gene amplification in ovarian cancer. (2006) (280)
The pathology of intermediate trophoblastic tumors and tumor-like lesions. (2001) (271)
Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers (2013) (269)
Fallopian tube precursors of ovarian low‐ and high‐grade serous neoplasms (2013) (263)
Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. (1995) (261)
Diagnosis and staging of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis--report of the Radiology Diagnostic Oncology Group. (1999) (260)
Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. (1999) (259)
Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. (1999) (253)
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial (2017) (252)
Determinants of Genital Human Papillomavirus Infection in Low‐Risk Women in Portland, Oregon (1993) (249)
Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. (1991) (245)
Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci (2005) (243)
Tumors of the cervix, vagina, and vulva (1992) (235)
Basaloid and Warty Carcinomas of the Vulva: Distinctive Types of Squamous Cell Carcinoma Frequently Associated with Human Papillomaviruses (1993) (233)
Immunohistochemical Evidence Supporting the Appendiceal Origin of Pseudomyxoma Peritonei in Women (1997) (232)
Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. (1998) (232)
Surface Epithelial Tumors of the Ovary (2011) (232)
Human Papillomavirus Type-Distribution in Vulvar and Vaginal Cancers and Their Associated Precursors (2009) (230)
Tumors of the uterine corpus and gestational trophoblastic disease (1992) (230)
Cellular localization of alpha‐fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis using an indirect immunoperoxidase technique. A new approach to classification utilizing tumor markers (1977) (227)
Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors. (1999) (221)
Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin? (2010) (216)
Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression. (1998) (214)
Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. (2008) (210)
In situ and invasive vulvar cancer incidence trends (1973 to 1987). (1992) (209)
Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation. (2000) (207)
Histological characteristics of breast carcinoma in blacks and whites. (1994) (198)
Mutation and Loss of Expression of ARID1A in Uterine Low-grade Endometrioid Carcinoma (2011) (198)
Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses. (2012) (196)
Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well‐differentiated carcinoma (1982) (195)
HLA-G is a potential tumor marker in malignant ascites. (2003) (195)
Mutations of BRAF and KRAS Precede the Development of Ovarian Serous Borderline Tumors (2004) (194)
Clear-cell adenocarcinoma of the genital tract in young females. Registry report. (1972) (193)
Precancerous Lesions of the Cervix (1994) (193)
Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms (2006) (192)
Heterogeneous etiology of squamous carcinoma of the vulva (1996) (192)
Low‐grade serous carcinomas of the ovary contain very few point mutations (2012) (191)
Trophoblastic pseudotumor of the uterus. An exaggerated form of “syncytial endometritis” simulating a malignant tumor (1976) (191)
Intrauterine progesterone treatment of early endometrial cancer. (2002) (191)
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine. (2008) (190)
Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas. (2009) (186)
Cytokeratins 7 and 20, Dpc4, and MUC5AC in the Distinction of Metastatic Mucinous Carcinomas in the Ovary From Primary Ovarian Mucinous Tumors: Dpc4 Assists in Identifying Metastatic Pancreatic Carcinomas (2002) (182)
Pathologic models to predict outcome for women with endometrial adenocarcinoma: The importance of the distinction between surgical stage and clinical stage‐‐A gynecologic oncology group study (1996) (181)
The Distribution of Low and High-risk HPV Types in Vulvar and Vaginal Intraepithelial Neoplasia (VIN and VaIN) (2006) (180)
Determinants of Genital Human Papillomavirus Infection in Low‐Income Women in Washington, D.C (1993) (177)
Cofactors with human papillomavirus in a population-based study of vulvar cancer. (1997) (175)
The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. A gynecologic oncology group study (1995) (174)
Immunocytochemical localization of placental lactogen and chorionic gonadotropin in the normal placenta and trophoblastic tumors, with emphasis on intermediate trophoblast and the placental site trophoblastic tumor. (1984) (171)
Histologic Alterations in Endometrial Hyperplasia and Well-differentiated Carcinoma Treated With Progestins (2007) (171)
Probable Nonpapillomavirus Etiology of Squamous Cell Carcinoma of the Vulva in Older Women: A Clinicopathologic Study Using In Situ Hybridization and Polymerase Chain Reaction (1991) (169)
Mesenchymal tumors of the uterus VI. Epithelioid smooth muscle tumors including leiomyoblastoma and clear‐cell leiomyoma. A clinical and pathologic analysis of 26 cases (1976) (163)
The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas: a clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites. (1997) (162)
The behavior of serous tumors of low malignant potential: are they ever malignant? (1993) (161)
Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma. (2014) (160)
Diagnostic Criteria and Behavior of Ovarian Seromucinous (Endocervical-Type Mucinous and Mixed Cell-Type) Tumors: Atypical Proliferative (Borderline) Tumors, Intraepithelial, Microinvasive, and Invasive Carcinomas (2002) (160)
Analysis of individual cervical human papillomavirus types in neolasia: A possible role for type 18 in rapid progression (1988) (159)
Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study. (1990) (159)
Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study. (1995) (156)
A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses. (1997) (156)
Refined Diagnostic Criteria for Implants Associated With Ovarian Atypical Proliferative Serous Tumors (Borderline) and Micropapillary Serous Carcinomas (2001) (154)
Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers (2018) (154)
Calretinin, a More Sensitive but Less Specific Marker Than &agr;-Inhibin for Ovarian Sex Cord-Stromal Neoplasms: An Immunohistochemical Study of 215 Cases (2002) (151)
Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. (2003) (148)
A Binary Architectural Grading System for Uterine Endometrial Endometrioid Carcinoma Has Superior Reproducibility Compared With FIGO Grading and Identifies Subsets of Advance-Stage Tumors With Favorable and Unfavorable Prognosis (2000) (148)
Interobserver and Intraobserver Variability of a Two-tier System for Grading Ovarian Serous Carcinoma (2007) (147)
Noninvasive and Invasive Micropapillary (Low-Grade) Serous Carcinoma of the Ovary: A Clinicopathologic Analysis of 135 Cases (2003) (146)
Diagnosis of Serous Tubal Intraepithelial Carcinoma Based on Morphologic and Immunohistochemical Features: A Reproducibility Study (2011) (145)
Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer. (2003) (144)
Malignant Mixed Germ Cell Tumors of the Ovary: A Clinical and Pathologic Analysis of 30 Cases (1976) (144)
Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas. (1997) (143)
Molecular Pathogenesis of Ovarian Borderline Tumors: New Insights and Old Challenges (2005) (143)
Inactivation of the mitogen-activated protein kinase pathway as a potential target-based therapy in ovarian serous tumors with KRAS or BRAF mutations. (2005) (143)
Immunoperoxidase localization of papillomavirus antigens in cervical dysplasia and vulvar condylomas. (1981) (142)
Loss of ARID1A Expression Is an Early Molecular Event in Tumor Progression From Ovarian Endometriotic Cyst to Clear Cell and Endometrioid Carcinoma (2012) (141)
Papillary Tubal Hyperplasia: The Putative Precursor of Ovarian Atypical Proliferative (Borderline) Serous Tumors, Noninvasive Implants, and Endosalpingiosis (2011) (140)
The Development of High-grade Serous Carcinoma From Atypical Proliferative (Borderline) Serous Tumors and Low-grade Micropapillary Serous Carcinoma: A Morphologic and Molecular Genetic Analysis (2007) (140)
Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection. (1999) (139)
Borderline ovarian tumors: key points and workshop summary. (2004) (139)
Embryonal carcinoma of the ovary. A clinicopathologic entity distinct from endodermal sinus tumor resembling embryonal carcinoma of the adult testis (1976) (139)
Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma. (2005) (138)
Shortened Telomeres in Serous Tubal Intraepithelial Carcinoma: An Early Event in Ovarian High-grade Serous Carcinogenesis (2010) (137)
Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives. (2004) (135)
p63 Expression Is Useful in the Distinction of Epithelioid Trophoblastic and Placental Site Trophoblastic Tumors by Profiling Trophoblastic Subpopulations (2004) (135)
The Significance of Epithelial Differences in Mixed Mesodermal Tumors of the Uterus: A Clinicopathologic and Immunohistochemical Study (1990) (134)
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma (2017) (133)
Evaluation of the woman with postmenopausal bleeding: Society of Radiologists in Ultrasound‐Sponsored Consensus Conference statement. (2001) (133)
Human papillomavirus deoxyribonucleic acid in cervical carcinoma from primary and metastatic sites. (1986) (131)
Possible prognostic significance of human papillomavirus type in cervical cancer. (1988) (131)
Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance (2007) (130)
Characterization of Active Mitogen-Activated Protein Kinase in Ovarian Serous Carcinomas (2004) (130)
Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors. (1998) (129)
Ki-67 labeling index in the differential diagnosis of exaggerated placental site, placental site trophoblastic tumor, and choriocarcinoma: a double immunohistochemical staining technique using Ki-67 and Mel-CAM antibodies. (1998) (129)
Endocervical Adenocarcinomas With Ovarian Metastases: Analysis of 29 Cases With Emphasis on Minimally Invasive Cervical Tumors and the Ability of the Metastases to Simulate Primary Ovarian Neoplasms (2008) (129)
Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States. (1998) (127)
Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix (2003) (127)
A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high‐grade serous carcinoma development (2014) (125)
A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival (2006) (125)
Mutational Analysis of K-ras Segregates Ovarian Serous Carcinomas into Two Types: Invasive MPSC (Low-grade Tumor) and Conventional Serous Carcinoma (High-grade Tumor) (2003) (125)
Biochemical epidemiology of cervical neoplasia: measuring cigarette smoke constituents in the cervix. (1987) (124)
Fatty acid synthase expression in endometrial carcinoma (1998) (123)
Validation of an Algorithm for the Diagnosis of Serous Tubal Intraepithelial Carcinoma (2012) (122)
Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study (2016) (122)
A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells (2001) (121)
Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix. (2000) (121)
Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity (2000) (121)
Synchronous and Metachronous Endocervical and Ovarian Neoplasms: Evidence Supporting Interpretation of the Ovarian Neoplasms as Metastatic Endocervical Adenocarcinomas Simulating Primary Ovarian Surface Epithelial Neoplasms (2005) (119)
HLA-G Immunoreactivity Is Specific for Intermediate Trophoblast in Gestational Trophoblastic Disease and Can Serve as a Useful Marker in Differential Diagnosis (2002) (118)
Endometrioid and clear cell carcinoma of the ovary (1972) (116)
Expression of melanoma cell adhesion molecule in intermediate trophoblast. (1996) (115)
PD-L1 Expression in Human Placentas and Gestational Trophoblastic Diseases (2016) (112)
Comparison of estrogen and progesterone receptor, Ki-67, and p53 immunoreactivity in uterine endometrioid carcinoma and endometrioid carcinoma with squamous, mucinous, secretory, and ciliated cell differentiation. (1998) (112)
Placental site nodule and characterization of distinctive types of intermediate trophoblast. (1999) (111)
Ovarian Cancer is an Imported Disease: Fact or Fiction? (2012) (110)
A Clinicopathologic Analysis of Atypical Proliferative (Borderline) Tumors and Well-Differentiated Endometrioid Adenocarcinomas of the Ovary (2000) (110)
Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens (1997) (108)
Gestational Trophoblastic Disease and Related Lesions (1994) (106)
Well‐Differentiated Villoglandular Adenocarcinoma of the Uterine Cervix: A Clinicopathological Study of 24 Cases (1993) (105)
Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma. (2002) (105)
The morphology, biology, and pathology of intermediate trophoblast: a look back to the present. (1991) (105)
Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary. (1997) (103)
Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions. (1999) (101)
Malignant germ cell tumors of the ovary. (1977) (99)
A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue. (1998) (99)
The 2001 Bethesda system: Terminology for reporting results of cervical cytology (2002) (99)
The Fallopian Tube-Peritoneal Junction: A Potential Site of Carcinogenesis (2011) (98)
Inhibin and Epithelial Membrane Antigen Immunohistochemistry Assist in the Diagnosis of Sex Cord‐Stromal Tumors and Provide Clues to the Histogenesis of Hypercalcemic Small Cell Carcinomas (1998) (98)
Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. (1982) (97)
World Health Organisation Classification of Tumours of the Female Reproductive Organs (2014) (95)
Benign Diseases of the Endometrium (1987) (95)
HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma. (2005) (94)
Endometrial Hyperplasia and Related Cellular Changes (1994) (93)
Transvaginal color Doppler sonography of adnexal masses: differences in blood flow impedance in benign and malignant lesions. (1993) (93)
Cystic and Adenofibromatous Clear Cell Carcinomas of the Ovary: Distinctive Tumors That Differ in Their Pathogenesis and Behavior: A Clinicopathologic Analysis of 122 Cases (2009) (93)
Clear cell carcinoma of the endometrium. An analysis of 21 cases (1976) (92)
Treatment plans for black and white women with stage II node‐positive breast cancer: The national cancer institute black/white cancer survival study experience (1992) (92)
Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus (1992) (91)
DNA Copy Numbers Profiles in Affinity-Purified Ovarian Clear Cell Carcinoma (2010) (90)
Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix. (1997) (90)
Thickened endometrium in the postmenopausal woman: sonographic-pathologic correlation. (1993) (90)
Correlation of Cellular Atypia and Human Papillomavirus Deoxyribonucleic Acid Sequences in Exfoliated Cells of the Uterine Cervix (1986) (89)
Molecular basis of gestational trophoblastic diseases. (2002) (89)
Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase (2010) (89)
Somatic mutations of PPP2R1A in ovarian and uterine carcinomas. (2011) (88)
Placental Site Nodules and Plaques A Clinicopathologic Analysis of 20 Cases (1990) (88)
Cyclin E and p16 Immunoreactivity in Epithelioid Trophoblastic Tumor—An Aid in Differential Diagnosis (2006) (87)
Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. (1998) (87)
The significance of squamous differentiation in endometrial carcinoma. Data from a Gynecologic Oncology Group study. (1991) (84)
Defining the Cut Point Between Low-grade and High-grade Ovarian Serous Carcinomas: A Clinicopathologic and Molecular Genetic Analysis (2009) (81)
Possible etiologic heterogeneity of vulvar intraepithelial neoplasia. A correlation of pathologic characteristics with human papillomavirus detection by in situ hybridization and polymerase chain reaction (1991) (81)
From Papanicolaou to Bethesda: The rationale for a new cervical cytologic classification (1991) (80)
Precursor Lesions of Endometrial Carcinoma (2011) (80)
Immunohistochemistry of Choriocarcinoma: An Aid in Differential Diagnosis and in Elucidating Pathogenesis (2007) (80)
The revised Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda workshop. (1992) (80)
Pathology of ovarian carcinoma. (2003) (79)
Precursor Lesions of High-Grade Serous Ovarian Carcinoma: Morphological and Molecular Characteristics (2010) (79)
Antigen‐specific cancer immunotherapy using a GM‐CSF secreting allogeneic tumor cell‐based vaccine (2000) (77)
Cytogenetic profile of uterine sarcomas (1993) (77)
Lack of Expression of c-kit Protein (CD117) in Mesenchymal Tumors of the Uterus and Ovary (2003) (76)
The Role of E-cadherin in the Motility and Invasion of Implantation Site Intermediate Trophoblast. (2002) (76)
Oral contraceptive use, human papillomavirus infection, and risk of early cytological abnormalities of the cervix. (1990) (76)
Symposium: ovarian tumors of borderline malignancy. (1996) (75)
"ASCUS, rule out HSIL": cytologic features, histologic correlates, and human papillomavirus detection. (1999) (73)
Diagnosis of Endometrial Biopsies and Curettings: A Practical Approach (1995) (72)
Carcinoma and Other Tumors of the Cervix (2019) (72)
Effect of the Yuzpe regimen of emergency contraception on markers of endometrial receptivity. (2000) (70)
The role of human papillomaviruses in the pathogenesis and histologic classification of precancerous lesions of the cervix. (1986) (69)
Verrucous Carcinoma of the Vulva Associated With an Unusual Type 6 Human Papillomavirus (1986) (68)
The significance of squamous differentiation in endometrial carcinoma. Data from a gynecologic oncology group study (1991) (68)
CCNE1 Amplification and Centrosome Number Abnormality in Serous Tubal Intraepithelial Carcinoma- Further Evidence Supporting its Role as a Precursor of Ovarian High-Grade Serous Carcinoma (2016) (68)
Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas. (1998) (67)
Evaluation of histologic, morphometric, and immunohistochemical criteria in the differential diagnosis of small cell carcinomas of the cervix with particular reference to human papillomavirus types 16 and 18. (1991) (67)
Endocervical-type Mucinous Borderline Tumors are Related to Endometrioid Tumors Based on Mutation and Loss of Expression of ARID1A (2012) (67)
Expression of Mel-CAM in implantation site intermediate trophoblastic cell line, IST-1, limits its migration on uterine smooth muscle cells. (1998) (66)
Proliferations and tumors of intermediate trophoblast of the placental site. (1988) (66)
Ovarian Brenner tumour: a morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium. (2013) (63)
Diagnostic Reproducibility of Hydatidiform Moles: Ancillary Techniques (p57 Immunohistochemistry and Molecular Genotyping) Improve Morphologic Diagnosis (2012) (63)
The incidence and histogenesis of vaginal adenosis. An autopsy study. (1974) (62)
Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions (2019) (62)
Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix. (1996) (61)
Endometrial blood flow analysis in postmenopausal women: can it help differentiate benign from malignant causes of endometrial thickening? (1995) (60)
An immunohistological study of steroid localization in sertoli‐leydig tumors of the ovary and testis (1978) (60)
Morphology and DNA content analysis in the evaluation of first trimester placentas for partial hydatidiform mole (PHM). (2000) (59)
Molecular genetic analysis of ovarian serous cystadenomas (2004) (59)
Tissue effects of and host response to human papillomavirus infection. (1987) (59)
Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom (2002) (59)
Cervical adenoid basal tumors comprised of adenoid basal epithelioma associated with various types of invasive carcinoma: clinicopathologic features, human papillomavirus DNA detection, and P16 expression. (2005) (58)
Identification of patients with stage I uterine endometrioid adenocarcinoma at high risk of recurrence by DNA ploidy, myometrial invasion, and vascular invasion. (1992) (58)
Homozygous deletion of MKK4 in ovarian serous carcinoma (2006) (58)
HSD3B1 as a Novel Trophoblast-associated Marker That Assists in the Differential Diagnosis of Trophoblastic Tumors and Tumorlike Lesions (2008) (58)
Current concepts in the relationship of human papillomavirus infection to the pathogenesis and classification of precancerous squamous lesions of the uterine cervix. (1990) (57)
Expression of Fatty Acid Synthase Is Closely Linked to Proliferation and Stromal Decidualization in Cycling Endometrium (1997) (56)
Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferative serous tumors and serous carcinomas. (2002) (55)
Pathology of borderline (low malignant potential) ovarian tumours. (2002) (55)
Molecular genetic analysis of placental site trophoblastic tumors and epithelioid trophoblastic tumors confirms their trophoblastic origin. (2002) (54)
Reassessment of the morphological continuum of cervical intraepithelial lesions: does it reflect different stages in the progression to cervical carcinoma? (1992) (54)
Diagnosis of Endometrial Biopsies and Curettings (1995) (54)
Villoglandular adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases: a gynecologic oncology group study. (1998) (54)
Embryonal carcinoma of the ovary: a clinicopathologic entity distinct from endodermal sinus tumor resembling embryonal carcinoma of the adult testis. (1977) (52)
Norethindrone Acetate and Estradiol‐Induced Endometrial Hyperplasia (2000) (52)
A nationwide study of serous "borderline" ovarian tumors in Denmark 1978-2002: centralized pathology review and overall survival compared with the general population. (2014) (52)
Endometrial hyperplasia and carcinoma. Diagnostic considerations. (1983) (52)
Seromucinous Tumors of the Ovary. What's in a Name? (2016) (51)
Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants (2014) (51)
Endometrial cancer chemoprevention: Implications of diverse pathways of carcinogenesis (1995) (51)
Longitudinal Evaluation of Interobserver and Intraobserver Agreement of Cervical Intraepithelial Neoplasia Diagnosis Among an Experienced Panel of Gynecologic Pathologists (2007) (50)
Squamous differentiation in carcinoma of the endometrium: a critical appraisal of adenoacanthoma and adenosquamous carcinoma. (1988) (50)
Two Types of Ovarian Cortical Inclusion Cysts: Proposed Origin and Possible Role in Ovarian Serous Carcinogenesis (2015) (50)
Salpingitis, Salpingoliths, and Serous Tumors of the Ovaries: Is There a Connection? (2002) (49)
BRAF Mutation Is Associated With a Specific Cell Type With Features Suggestive of Senescence in Ovarian Serous Borderline (Atypical Proliferative) Tumors (2014) (49)
Clinical significance of Her-2/neu overexpression in uterine serous carcinoma. (2006) (49)
Clear cell carcinoma of the endometrium: an analysis of 21 cases. (1976) (49)
Ki-67 Labeling Index as an Adjunct in the Diagnosis of Serous Tubal Intraepithelial Carcinoma (2012) (49)
Predicting the outcome of endometrial hyperplasia by quantitative analysis of nuclear features using a linear discriminant function. (1983) (48)
Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population. (2019) (48)
Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: Results from a seroepidemiological case-control study (1997) (48)
Steroid localization in granulosa‐theca tumors of the ovary (1979) (48)
The Diagnostic and Biological Implications of Laminin Expression in Serous Tubal Intraepithelial Carcinoma (2012) (47)
Micropapillary Serous Carcinoma of the Ovary (1997) (47)
Subdividing Ovarian and Peritoneal Serous Carcinoma Into Moderately Differentiated and Poorly Differentiated Does not Have Biologic Validity Based on Molecular Genetic and In Vitro Drug Resistance Data (2008) (47)
Detection of estrogen receptor in breast and endometrial carcinoma by the immunoperoxidase technique (1981) (46)
Cellular localization of alpha-fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis using and indirect immunoperoxidase technique. (1977) (46)
Histopathologic features of ovaries at increased risk for carcinoma. A case-control analysis. (1999) (46)
The diagnosis of ovarian cancer by pathologists: how often do diagnoses by contributing pathologists agree with a panel of gynecologic pathologists? (1991) (45)
Clonality analysis of combined Brenner and mucinous tumours of the ovary reveals their monoclonal origin (2015) (44)
Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease. (1997) (44)
Analysis of cytokine profiles in patients with human papillomavirus-associated neoplasms. (1997) (44)
The Bethesda System. A proposal for reporting abnormal cervical smears based on the reproducibility of cytopathologic diagnoses. (1992) (44)
Pathological characteristics of cervical adenocarcinoma in a multi-center U.S.-based study (2006) (44)
Diagnostic Reproducibility of Hydatidiform Moles: Ancillary Techniques (p57 Immunohistochemistry and Molecular Genotyping) Improve Morphologic Diagnosis for Both Recently Trained and Experienced Gynecologic Pathologists (2012) (44)
Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma. (2006) (44)
Human Papillomavirus Type 16 and Risk of Preinvasive and Invasive Vulvar Cancer: Results From a Seroepidemiological Case‐control Study (1997) (43)
Survival Rates for International Federation of Gynecology and Obstetrics Stage III Ovarian Carcinoma by Cell Type: A Study of 262 Unselected Patients With Uniform Pathologic Review (2012) (43)
New concepts in trophoblastic growth and differentiation with practical application for the diagnosis of gestational trophoblastic disease. (1997) (42)
Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases (2017) (41)
A binary histologic grading system for ovarian serous carcinoma is an independent prognostic factor: a population-based study of 4317 women diagnosed in Denmark 1978-2006. (2012) (41)
Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis. (2010) (41)
Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study (2018) (40)
Steroid hormone synthesis by the ovarian stroma surrounding epithelial ovarian tumors: a potential mechanism in ovarian tumorigenesis (2017) (40)
Protocol for the examination of specimens from patients with carcinomas of the cervix: a basis for checklists. Cancer Committee, College of American Pathologists. (2009) (40)
A nationwide study of ovarian serous borderline tumors in Denmark 1978-2002. Risk of recurrence, and development of ovarian serous carcinoma. (2017) (39)
Human papillomavirus: detection of viral DNA sequences and evidence for molecular heterogeneity in metaplasias and dysplasias of the uterine cervix. (1983) (39)
Nuclear size distinguishes low- from high-grade ovarian serous carcinoma and predicts outcome. (2005) (39)
Micropapillary Serous Carcinoma of the Ovary: An Immunohistochemical and Mutational Analysis of p53 (1998) (39)
Precursors of endometrial and ovarian carcinoma (2009) (38)
The potential value of immunohistologic techniques in the classification of ovarian and testicular tumors. (1978) (37)
Elevated nicotine levels in cervical lavages from passive smokers. (1991) (37)
Detection of allelic imbalance in ascitic supernatant by digital single nucleotide polymorphism analysis. (2002) (37)
Lipomatous variant of angiomyofibroblastoma: report of two cases and review of the literature. (2005) (36)
Definitions and Explanatory Notes (1994) (36)
The pathogenesis of atypical proliferative Brenner tumor: an immunohistochemical and molecular genetic analysis (2014) (35)
Diagnostic potential of tumor DNA from ovarian cyst fluid (2016) (35)
Characterization of the Immune Cell Repertoire in the Normal Fallopian Tube (2014) (34)
CD10 Immunostaining Does Not Distinguish Endometrial Carcinoma Invading Myometrium From Carcinoma Involving Adenomyosis (2003) (34)
Gestational Trophoblastic Disease (2018) (34)
Evaluation of Microinvasion and Lymph Node Involvement in Ovarian Serous Borderline/Atypical Proliferative Serous Tumors: A Morphologic and Immunohistochemical Analysis of 37 Cases (2014) (33)
Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma (2011) (32)
Expression of Extracellular Matrix Proteins in Ovarian Serous Tumors (2007) (30)
Endometrial Neoplasia: Hyperplasia and Carcinoma (1982) (29)
Statement of caution in the interpretation of papillomavirus-associated lesions of the epithelium of uterine cervix. (1983) (29)
Malignant germ cell tumors of the ovary and testis. An immunohistologic study of 69 cases. (1979) (29)
Gross Description, Processing, and Reporting of Gynecologic and Obstetric Specimens (1987) (27)
p16 Immunohistochemistry Improves Interobserver Agreement in the Diagnosis of Cervical Intraepithelial Neoplasia (2002) (27)
Pathologic features associated with resolution of complex atypical hyperplasia and grade 1 endometrial adenocarcinoma after progestin therapy. (2014) (27)
Papillomavirus infection of the cervix. III: Relationship of the presence of viral structural proteins to the expression of involucrin. (1984) (26)
Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study. (2017) (26)
Progesterone secreting Sertoli cell tumor of the ovary. (1985) (25)
Low-grade Serous Carcinoma of the Ovary Displaying a Macropapillary Pattern of Invasion (2008) (25)
Endometrial Hyperplasia and Metaplasia (1987) (24)
Pathology of trophoblast. (1991) (24)
Review Ovarian Tumorigenesis A Proposed Model Based on Morphological and Molecular Genetic Analysis (2004) (24)
Human papillomavirus-specific serologic response in vulvar neoplasia. (1996) (23)
Trophoblastic disease (2012) (23)
The Relationship of Glands to Thick-Wall Blood Vessels as a Marker of Invasion in Endocervical Adenocarcinoma (2005) (23)
Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial. (2021) (23)
Perforin Expression in Endometrium During the Menstrual Cycle (1995) (23)
Endometrial Morphology and Polyethylene Intrauterine Devices: A Study of 200 Endometrial Biopsies (1968) (23)
Pathological characteristics of cervical adenocarcinoma in a multi-center US-based study. (2007) (23)
Gestational Trophoblastic Tumors and Related Tumorlike Lesions (2011) (22)
Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age. (2018) (22)
The Bethesda System (1993) (22)
Clinicopathologic and Molecular Features of Paired Cases of Metachronous Ovarian Serous Borderline Tumor and Subsequent Serous Carcinoma (2019) (21)
Trophoblastic neoplasms express fatty acid synthase, which may be a therapeutic target via its inhibitor C93. (2009) (21)
Tamoxifen and the endometrium. (1999) (21)
PAPILLOMAVIRUS AND CERVICAL DYSPLASIA (1980) (21)
Germ cell tumors of the ovary. (1978) (21)
Chondrosarcoma secreting chorionic gonadotropin: report of a case. (1977) (20)
Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas (Cancer Research (2009) 69, (4036-42)) (2009) (20)
Ovarian serous borderline tumors: the citadel defended. (2000) (20)
Detection of papillomavirus common antigens in lesions of skin and mucosa. (1985) (19)
Regarding mutagenic mucus in the cervix of smokers. (1987) (19)
Bokhman's dualistic model of endometrial carcinoma. Revisited. (2013) (19)
Molecular analysis of ovarian mucinous carcinoma reveals different cell of origins (2015) (18)
Discovery of a Cell: Reflections on the Checkered History of Intermediate Trophoblast and Update on its Nature and Pathologic Manifestations (2014) (18)
Two types of primary mucinous ovarian tumors can be distinguished based on their origin (2019) (18)
Calretinin, a More Sensitive but Less Specific Marker Than -Inhibin for Ovarian Sex Cord-Stromal Neoplasms (2002) (18)
Effects of Hormones (2018) (17)
Analysis of histopathological features of endometrioid uterine carcinomas and epidemiologic risk factors. (1998) (17)
Evaluation of PAPNET testing as an ancillary tool to clarify the status of the "atypical" cervical smear. (1997) (17)
Association of Ulex europaeus agglutinin I binding with invasion in endometrial carcinoma. (1993) (17)
Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma (2015) (17)
Neonatal estrogenic exposure suppresses PTEN-related endometrial carcinogenesis in recombinant mice (2006) (17)
Failure to detect human papillomavirus in Kaposi's sarcoma (1992) (17)
Preinvasive lesions of the endometrium. (1986) (16)
Comprar Blaustein's Pathology of the Female Genital Tract 6ed | Hedrick Ellenson, Lora | 9781441904881 | Springer (2010) (16)
Placental site trophoblastic tumor--past as prologue. (2001) (16)
Profiling the activity of G proteins in patient‐derived tissues by rapid affinity‐capture of signal transduction proteins (GRASP) (2004) (15)
The Bethesda System. Impact on reporting cervicovaginal specimens and reproducibility of criteria for assessing endocervical sampling. (1993) (15)
Comparison of peroxidase-labeled DNA probes with radioactive RNA probes for detection of human papillomaviruses by in situ hybridization in paraffin sections. (1991) (15)
Evolving concepts in endometrial carcinogenesis: importance of DNA repair and deregulated growth. (1998) (15)
Vulvar condylomas and squamous vestibular micropapilloma. Differences in appearance and response to treatment. (1990) (14)
HPV-16 viral transcripts in vulvar neoplasia: preliminary studies. (1991) (14)
Distribution of cells bearing the HNK-1 epitope in the human placenta. (1997) (14)
Recurrent serous borderline tumors of the ovary. (1998) (13)
Intraepithelial carcinoma of the cervix (1998) (13)
Normal Endometrium and Infertility Evaluation (2005) (13)
The role of exfoliative cytology and histopathology in screening and triage. (1996) (13)
Recent advances in the pathology of ovarian cancer. (1983) (13)
Choriocarcinoma and Placental Site Trophoblastic Tumor (1987) (13)
Intratumoral Heterogeneity Accounts for Apparent Progression of Noninvasive Serous Tumors to Invasive Low-grade Serous Carcinoma: A Study of 30 Low-grade Serous Tumors of the Ovary in 18 Patients With Peritoneal Carcinomatosis (2020) (12)
Spina bifida with associated choristoma of Müllerian origin (1969) (12)
The pathologic features and behavior of endometrial carcinoma associated with exogenous estrogen administration. (1982) (12)
Lack of a Y-Chromosomal Complement in the Majority of Gestational Trophoblastic Neoplasms (2010) (12)
A seroepidemiologic study of HPV infection and incident cervical squamous intraepithelial lesions. (1994) (12)
Ki-67 Index as an Ancillary Tool in the Differential Diagnosis of Proliferative Endometrial Lesions With Secretory Change (2014) (12)
THE INCIDENCE AND HISTOGENESIS OF VAGINAL ADENOSIS (1975) (12)
Characterization and Comparison of Precursors of Ovarian and Endometrial Carcinoma: Parts I and II (2010) (11)
Histological Classification of Tumours of the Female Genital Tract (1994) (11)
Lower extremity paralysis after operative laparoscopy from conversion disorder. A case report. (1998) (11)
Pseudoinfiltrative Tubal Metaplasia of the Endocervix: A Potential Form of In Utero Diethylstilbestrol Exposure-Related Adenosis Simulating Minimal Deviation Adenocarcinoma (2005) (11)
Molecular pathology of gynecologic cancer (2007) (10)
Evidence for at least two distinct groups of humoral immune reactions to papillomavirus antigens in women with squamous intraepithelial lesions. (1997) (10)
Decreased progesterone receptor expression in the intermediate trophoblastic cells of spontaneous abortions. (2002) (9)
Papillomaviruses in Anogenital Neoplasms (1986) (9)
Grading of endometrial carcinoma. (1991) (8)
Reproducibility of the histopathological classification of vulvar squamous carcinoma and intraepithelial neoplasia. (1999) (8)
Detection of Chlamydia trachomatis DNA in archival paraffinized specimens from chronic salpingitis cases using the polymerase chain reaction. (2000) (8)
Endometrial Hyperplasia, Endometrial Intraepithelial Carcinoma, and Epithelial Cytoplasmic Change (2005) (7)
Demonstration of human papillomavirus (HPV) genomic amplification and viral-like particles from CaSki cell line in SCID mice. (1997) (7)
HPV in situ hybridization with catalyzed signal amplification and polymerase chain reaction in establishing cerebellar metastasis of a cervical carcinoma. (1999) (7)
Probable Nonpapiilomavirus Etiology of Squamous Cell Carcinoma of the Vulva in Older Women: A Clinicopathologic Study Using In Situ Hybridization and Polymerase Chain Reaction (1991) (6)
Bovine papillomavirus type 1 monoclonal antibodies. (1985) (6)
Risk of specific types of ovarian cancer after borderline ovarian tumors in Denmark: A nationwide study (2020) (6)
Evaluation of the Woman With Postmenopausal Bleeding (2002) (6)
Endometrial stromal invasion in the diagnosis of well-differentiated carcinoma. (1984) (6)
Papillomavirus infection and squamous neoplasia of the cervix. (1984) (6)
The behavior of endometrial hyperplasia: A long-term study of “untreated” hyperplasia in 170 patients (1985) (6)
Comprehensive Surgical Staging in Stage 1 Clear Cell and Endometrioid Ovarian Carcinomas: Is it Necessary? (2019) (6)
Detection of the Human Cytomegalovirus 2.0-kb Immediate Early Gene 1 Transcripts in Permissive and Nonpermissive Infections by RNA in situ Hybridization. (1997) (6)
Specimen Adequacy Definitions, Criteria, and Explanatory Notes (1994) (5)
Pathogenesis of Gestational Trophoblastic Lesions (2007) (5)
Why abandoning the borderline category of ovarian tumors is beneficial (1997) (5)
Secretion of human chorionic gonadotropin and alpha-fetoprotein by an ovarian germ cell tumor of apparent yolk sac origin. (1984) (5)
Descriptive Diagnoses Definitions, Criteria, and Explanatory Notes (1994) (5)
Ovarian intestinal-type mucinous borderline tumors: a nomenclature change is long overdue. (2010) (5)
Endometrial Hyperplasia and Epithelial Cytoplasmic Change (1995) (5)
Identification of human papillomavirus (HPV) sequences in female genital tract neoplasms (1985) (5)
Possible prognostic significance of HPV type in cervical cancer (1987) (4)
Risk of ovarian cancer after treatment for infertility. (2020) (4)
The Dualistic Model of Ovarian Carcinogenesis (4)
Synchronous and metachronous endocervical and ovarian neoplasms: A different interpretation of HPV data [6] (2005) (4)
Evolution of the concept and termiology of borderline ovarian tumours (2000) (4)
Atypical Proliferative (Borderline) Serous Tumor in the Brain: A Case Report. (2017) (3)
Methods of Endometrial Evaluation (2018) (3)
Germ Cell Tumors of the Ovary: Pathology, Behavior and Treatment (1983) (3)
Comprar Blaustein's Pathology of the Female Genital Tract 6th book + online access | Robert J. Kurman, | 9781441904904 | Springer (2010) (3)
Cellular Localization of AFP and HCG in Germ Cell Tumors of the Testis and Ovary (1978) (3)
Dysfunctional Uterine Bleeding (2005) (3)
Contributions of immunocytochemistry to gynaecological pathology. (1984) (3)
P095 Levormeloxifene, a non-steroidal estrogen receptor therapeutic, exerts a non-proliferative action on uterine tissues of the ovariectomized rat (1996) (2)
Tissue effects of and host response to human papillomavirus infection. (1991) (2)
The Effect of in Utero Exposure to Diethylstilbestrol (1980) (2)
Abstract 5536:TP53andMED12mutations in uterine smooth muscle tumors (2012) (2)
PAPILLOMAVIRUS AND CERVICAL DYSPLASIA (1981) (2)
Histologic Effects of Oral Contraceptives on the Uterine Corpus and Cervix (1989) (2)
Detection and Quantitation of Human Papillomavirus DNA in the Plasma of Patients with Cervical Carcinoma 1 (2002) (2)
Pregnancy, Abortion, and Ectopic Pregnancy (2018) (2)
Statement of caution in the interpretation of papillomavirus-associated lesions of the epithelium of uterine cervix. (1984) (2)
Perivascular Epithelioid Cell Tumors (PEComas) and Smooth Muscle Tumors of the Uterus (2007) (2)
New Views of Ovarian Carcinoma Types: How Will This Change Practice? (2014) (2)
Abnormalities of the genital tract following stilbestrol exposure in utero. (1979) (2)
The Bethesda System: “Pro” (1991) (2)
The identification of stromal invasion in the distinction of atypical endometrial hyperplasia from well differentiated adenocarcinoma. (1991) (2)
Caution in interpreting papillomavirus-associated lesions [letter] (1983) (1)
Introduction to the ISGYP Symposium on Endometrial Hyperplasia (2000) (1)
Analysis of Histopathological Features of Endometrioid Uterine (2012) (1)
Identifying Women With Cervical Neoplasia Using Human Papillomavirus DNA Testing for Equivocal Papanicolaou Results (1999) (1)
Ovarian Serous Carcinogenesis—A Proposed Model (2007) (1)
Re: Article by Natalie Banet and Robert J. Kurman: Two Types of Ovarian Cortical Inclusion Cysts: Proposed Origin and Possible Role in Ovarian Serous Carcinogenesis; Int. J. Gynecol. Pathol. 2015;34:3–8 (2015) (1)
OF THE OVARY AND TESTIS LOCALIZATION IN SERTOLI-LEYDIG TUMORS (1978) (1)
Comment on the article: The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaiN) Am j surg pathol. 2006;30 :151 3-1518 by Srodon M, et al., Authors' reply (2007) (1)
Endometrial Cancer in the Hereditary Nonpolyposis Colorectal Cancer Syndrome (2004) (1)
Effect of Nonionic Detergents on Amplification of Human Papillomavirus DNA with Consensus Primers MY09 and MY11 (1998) (1)
A quadrivalent vaccine prevented persistent infection and disease associated with HPV types 6, 11, 16, and 18 (2005) (1)
The Normal Endometrium (2018) (1)
Atypical smooth muscle tumors of the uterus. A clinical and pathologic analysis of 26 cases including leiomyoblastoma, epithelioid leiomyoma, and clear cell leiomyoma (1975) (1)
Caution in interpreting papillomavirus-associated lesions. (1983) (1)
Cervical HPV DNA Detection as a Predictor of a Recurrent SIL Diagnosis Among Untreated Women (2001) (1)
Mesenchymal Tumors and Other Rare Neoplasms (2018) (1)
Prevalence of Alternative Lengthening of Telomeres ( ALT ) in Human Cancer Subtypes (2011) (1)
The Distribution of HPV in VIN (2007) (1)
Localization of Epstein-Barr Virus-Encoded Small RNA-1 by in situ Reverse Transcription: Demonstration of cDNA Generation in Formalin-Fixed Paraffin-Embedded Tissue Sections. (1995) (1)
Pathogenesis of Ovarian Serous Carcinoma as the Basis for Immunologic Directed Diagnosis and Treatment. Project 2 - Identification of Autologous Antigens in Early Stage Serous Carcinoma (2003) (1)
Statement of caution in the interpretation of papilloma virus‐associated lesions of the epithelium of uterine cervix (1983) (1)
Abstract 221:TP53mutations in serous tubal intraepithelial carcinoma, the putative precursor lesion of ovarian high-grade serous carcinoma (2011) (1)
Human papillomavirus. What role does it play in cervical cancer (1990) (1)
MINI-SYMPOSIUM: GYNAECOLOGICAL PATHOLOGY (2000) (0)
Is Human Papillomavirus a Primary Factor in the Causation of Cervical Neoplasia? Does Herpes Simplex Virus Play a Subordinate Role? (1989) (0)
Pathology of the uterine corpus. (1988) (0)
Comprar Molecular Pathology of Gynecologic Cancer | Giordano, Antonio | 9781588294531 | Springer (2007) (0)
Abstract MIP-074: CLUES FOR THE ORIGIN OF MUCINOUS OVARIAN TUMORS IN BRENNER TUMORS AND TERATOMAS? (2017) (0)
Correction: Article on DNA Copy Number Alterations in Ovarian Cancer (2009) (0)
Short Communication Diverse Tumorigenic Pathways in Ovarian Serous Carcinoma (2002) (0)
Pathogenesis of Ovarian Serous Carcinoma as the Basis for Immunologic Directed Diagnosis and Treatment. Project 3 - Development of Antigen-Specific Cancer Vaccines for the Control of Ovarian Cancer (2003) (0)
Endometrial Carcinoma (2018) (0)
Elucidation of Molecular Alterations in Precursor Lesions of Ovarian Serous Carcinoma (2012) (0)
Correlation of molecular expression with efficacy of progestin treatment of complex atypical hyperplasia and grade 1 adenocarcinoma of the endometrium (2013) (0)
Borderline Ovarian Tumors (1998) (0)
Endometritis (2018) (0)
Isaac Kinde Endometrial Cancers Evaluation of DNA from the Papanicolaou Test to Detect Ovarian (2013) (0)
Letter: Adenosis. (1975) (0)
P-30. Low Doses of Norethindrone Acetate Effectively Reduce the Incidence of Endometrial Hyperplasia Associated with 1 mg 17-Estradiol (1998) (0)
Abstract LB-50: Overexpression ofPBX1is associated with recurrence and worse clinical outcome in patients with recurrent ovarian high-grade serous carcinoma (2010) (0)
Commentary (Seidman/Kurman): Update on Low Malignant Potential Ovarian Tumors (2000) (0)
Bleeding as a Predictor of Endometrial Histology in Postmenopausal Women on Unopposed Estrogen and Continuous-combined HRT: P-55. (1999) (0)
UPDATE OF PAPILLOMAVIRUS AND ITS RELATION TO CARCINOMA OF THE CERVIX (1984) (0)
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma (2017) (0)
Molecular Pathology of Ovarian Cancer (2013) (0)
Relative prevalence of 14 major anogenital HPVS in health and disease (1991) (0)
Stage I-B adenocarcinoma of the cervix: Clinicopathologic correlations (1990) (0)
O-155 Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist (LA) treated uterine leiomyomas (1997) (0)
Risk of nonovarian cancer in a nationwide‐based study of nearly 5000 women with borderline ovarian tumors in Denmark (2022) (0)
DNA methylation profiles in ovarian serous neoplasms nd their implications in ovarian carcinogenesis (2010) (0)
University of Southern Denmark Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers (2018) (0)
3H-labeled subgenomic mRNA probes can demonstrate subtle differences in human papilloma virus expression in preinvasive and invasive vulvar cancers (1991) (0)
Abnormal Uterine Bleeding (2018) (0)
Abstract LB-343: Shortened telomeres in serous tubal intraepithelial carcinoma: An early event in ovarian high-grade serous carcinogenesis (2010) (0)
Abstract IA4: A dualistic model of ovarian carcinogenesis (2013) (0)
Mel-CAM involves in the interaction of human uterine smooth muscle cells and trophoblast (1998) (0)
Gene may predict aggressive ovarian cancer (2005) (0)
The Menzin article reviewed (2000) (0)
Author response: Diagnostic potential of tumor DNA from ovarian cyst fluid (2016) (0)
Protocol applies to all invasive carcinomas of the vagina. (2005) (0)
Obstetrical and gynecological survey: Trophoblastic pseudotumor of the uterus (1977) (0)
Symposium on Adolescent Gynecology and Endocrinology. Part II: Secondary amenorrhea, hirsutism in adolescents and the clinical consequences of stilbestrol exposure in utero. The clinical consequences of stilbestrol exposure in utero. (1979) (0)
TITLE: Identification and Characterization of Genomic Amplifications in Ovarian Serous Carcinoma (2008) (0)
Integrated genomic analysis of STIC-associated high-grade serous carcinoma (2015) (0)
Molecular diagnostics of gynecologic neoplasms (2012) (0)
Letter the Editor Two Types of Ovarian Cortical Inclusion Cysts: Proposed Origin and Possi-ble Role in Ovarian Serous Carcinogenesis; (2015) (0)
Histopathology of endometrial carcinoma (2009) (0)
Human Papillomavirus DNA Detection in Cervical Specimens by Hybrid Capture: Correlation with Cytologic and Histologic Diagnoses of Squamous Intraepithelial Lesion of the Cervix (1997) (0)
Is Well-Differentiated Endometrioid Carcinoma of the Ovary Indeed an Invasive Carcinoma? (2001) (0)
AWARD NUMBER: W81XWH-11-2-0230 TITLE: Prevention of Ovarian High-Grade Serous Carcinoma by Elucidating Its Early Change (2013) (0)
Epithelial Tumors of the Ovary (2019) (0)
Prevention of Ovarian High-Grade Serous Carcinoma by Elucidating Its Early Changes (2013) (0)
Precursors of Endometrial Carcinoma (2018) (0)
HNK-1 reactive glycosphingolipids are expressed in trophoblastic columns of human placentas (1996) (0)
Erratum: Baseloid and warty carcinomas of the vulva: Distinctive types of squamous cell carcinoma frequently associated with human papillomaviruses (American Journal of Surgical Pathology (1993) 17:2 (133-145)) (1993) (0)
Pathogenesis of Ovarian Serous Carcinoma as the Basis for Immunologic Directed Diagnosis and Treatment. Project 1 - Molecular Characterization of Ovarian Serous Tumors Developing Along Different Pathways (2003) (0)
0292: P53 Mutation is Not Related to Drug Resistant Assays: Analysis of Purified High Grade Ovarian Serous Carcinomas (2006) (0)
Type specific patterns of human papilloma viral diseases in the lower genital tract (1986) (0)
Cervical cytology and reimbursement issues. (1990) (0)
Abstract 4764: The pathogenesis of ovarian Brenner tumors. (2013) (0)
Detection of human papillomavirus DNA sequences and evidence for molecular heterogeneity in premalignant lesions of the uterine cervix (1983) (0)
High grade serous ovarian carcinomas originate in the fallopian tube (2017) (0)
Comprar Blaustein's Pathology of the Female Genital Tract E-reference. Libro online | Hedrick Ellenson, Lora | 9781441904898 | Springer (2010) (0)
A 45-year-old female with abdominal pain, ascites, and bilateral uterine adnexal masses. (1992) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Robert J. Kurman?

Robert J. Kurman is affiliated with the following schools:

Robert J. Kurman's Academic­Influence.com Rankings

Why Is Robert J. Kurman Influential?

Robert J. Kurman's Published Works

Published Works

What Schools Are Affiliated With Robert J. Kurman?

Robert J. Kurman's AcademicInfluence.com Rankings